Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
studies as well as research in animal models demonstrated an effect of the thyroid hormones T3 and T4 on cancer proliferation, apoptosis, invasiveness and angiogenesis. Thyroid hormones mediate their effects on the cancer cell through several non-genomic pathways including activation of the plasma membrane receptor integrin αvβ3. Furthermore, cancer development and progression are affected by dysregulation of local bioavailability of thyroid hormones. Case-control and population-based studies provide conflicting results regarding the association between thyroid hormones and cancer. However, a large body of evidence suggests that subclinical and clinical hyperthyroidism increase the risk of several solid malignancies while hypothyroidism may reduce aggressiveness or delay the onset of cancer. Additional support is provided from studies in which dysregulation of the thyroid hormone axis secondary to cancer treatment or thyroid hormone supplementation was shown to affect cancer outcomes. Recent preclinical and clinical studies in various cancer types have further shown promising outcomes following chemical reduction of thyroid hormones or inhibition or their binding to the integrin receptor. This review provides a comprehensive overview of the preclinical and clinical research conducted so far.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osorio, J. C., Ni, A., Chaft, J. E., Pollina, R., Kasler, M. K., Stephens, D., Rodriguez, C., Cambridge, L., Rizvi, H., Wolchok, J. D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw640 · Cited by 659 · cited 2×
“In a recent study of 51 non-smallcell lung cancer patients treated with pembrolizumab, a PD1 inhibitor (160), 21% of patients developed hypothyroidism requiring thyroid hormone replacement, with 80% developing positive antithyroid antibodies.”
BackgroundThe clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
Wolter, P., Stefan, C., Decallonne, B., Dumez, H., Bex, M., Carmeliet, P., & Schöffski, P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604497 · Cited by 198
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2693 · Cited by 186
Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
Moeller, L. C., & Führer, D. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0219 · Cited by 184 · cited 1×
“A great deal of research has been conducted in recent decades to determine how thyroid hormones exert their growth-promoting effect (7).”
BackgroundBrandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · Thyroid · doi:10.1089/thy.2012.0500 · Cited by 86
Frick, L. R., Rapanelli, M., Bussmann, U. A., Klecha, A. J., Arcos, M. L. B., Genaro, A. M., & Cremaschi, G. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.013 · Cited by 55 · cited 1×
“Leukemia in vitro No direct effect of T3 and T4 (93)”
BackgroundLow thyroid hormone levels improve survival in murine model for ocular melanoma
Fabian, I. D., Rosner, M., Fabian, I., Vishnevskia-Dai, V., Zloto, O., Maman, E. S., Cohen, K., Ellis, M., Lin, H.-Y., Hercbergs, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3566 · Cited by 36 · cited 2×
“In vivo Studies in Other Cancer Models Protective effect of hypothyroidism was also shown for uveal melanoma, one of the most common and highly metastatic intraocular malignancies (84).”
BackgroundSelf-citation
Cited by
Li, S., Oliva, P., Zhang, L., Goodrich, J. A., McConnell, R., Conti, D. V., Chatzi, L., & Aung, M. (2025) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-024-00742-2 · Cited by 101
“PFAS may disrupt the thyroid hormone system based on in vitro and animal studies, leading to impaired thyroid function and an increased risk of thyroid cancer [56, 57].”
Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality
Planck, T., Hedberg, F., Calissendorff, J., & Nilsson, A. (2021) · Thyroid® · doi:10.1089/thy.2020.0388 · Cited by 35
Metadata
- Authors
- Krashin, E., Piekiełko-Witkowska, A., Ellis, M., & Ashur-Fabian, O.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2019-02-13
- Volume
- 10
- Pages
- 59-59
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2913645272
- Cited by
- 217
- References
- 7
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies. https://app.cochat.ai/papers/10.3389/fendo.2019.00059
- The paper
- Krashin, E., Piekiełko-Witkowska, A., Ellis, M., & Ashur-Fabian, O. (2019). Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2019.00059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.